Sativa Investments teams up with King’s College London to research cannabinoids for medicinal use


UK medicinal cannabis investor Sativa Investments PLC (NEX: SATI) has teamed up with King’s College London to research the impact of cannabinoids on inflammation and respiratory diseases.  Under the research agreement, Sativa will supply the university with specific strains of cannabis plants that contain various combinations of the spectrum of at least 113 known cannabinoids, subject to regulatory approval.

Ga naar Bron